Aphias Capital closes oversubscribed debut fund at $1.05B
What's the deal? Aphias Capital has closed its first fund, Aphias Capital Fund I, at just over $1.05 billion in commitments. The San Francisco firm, founded in 2025, beat its $900 million target and pushed past its hard cap, drawing 52 investors.
What's the endgame? Aphias makes control investments in North American healthcare services and essential services companies with recurring demand. It targets businesses with $5 million to $30 million of EBITDA, often as the first or second institutional investor, or as a corporate carve-out partner.
Who backed it? The fund drew public pension plans, health systems, insurers, endowments and foundations, family offices, and funds of funds. "In many ways, Aphias is a start-up 20 years in the making," said founder and managing partner Rob Wolfson. Nine of its professionals previously worked together at H.I.G. Capital, many for over a decade.
Why now? First-time funds above $1 billion remain rare. One tracker counted 71 first-time launches in the first nine months of 2026, down from 95 a year earlier, as limited partners concentrate commitments with established managers.
The signal: Investor appetite for specialist healthcare strategies has held up — healthcare funds raised $16.2 billion in the first half of 2026, though two managers took roughly two-thirds of that. Aphias's oversubscribed close points to LP conviction in experienced teams and the lower middle market, where entry multiples run lower and operational work can drive returns, rather than a broad easing of fundraising conditions.
Read more: lexblog.com
Image credit: Generated with Gemini